http://archive.fast-edgar.com/20240515/A52ZR22CZC2RA9QZ2U2Q2ZY2DRBTZZ22ZB62
Filed on: May 15, 2024
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended March 31, 2024
Or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________ to __________
COMMISSION FILE NUMBER 000-56237
SERVE ROBOTICS... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2024
Commission File Number: 001-40370
BITFARMS LTD.
(Exact Name of Registrant as Specified in Its Charter)
110 Yonge Street, Suite 1601, Toronto, Ontario, Canada M5C 1T4
More SEC Filings
View Older Stories-
Form 6-K Borr Drilling Ltd For: May 15
-
Form 6-K KONINKLIJKE PHILIPS NV For: May 15
-
Form 10-Q Renalytix plc For: Mar 31
-
Form 10-Q SK Growth Opportunities For: Mar 31
-
Form 144 ASIAFIN HOLDINGS CORP. Filed by: SEE UNICORN VENTURES SDN BHD
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 14 Filed by: Doyle Anthony
-
Form 8-K UNITED STATES ANTIMONY For: May 15
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 14 Filed by: Thackray Helen M.
-
Form SC 13D/A ADAMS DIVERSIFIED EQUITY Filed by: Saba Capital Management, L.P.
-
Form 10-Q Venus Concept Inc. For: Mar 31
-
Form 10-Q TREVENA INC For: Mar 31
-
Form 8-K ATAI Life Sciences N.V. For: May 14
-
Form 6-K Sportradar Group AG For: May 15
-
Form 8-K Adaptimmune Therapeutics For: May 14
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Galson Steven K
-
Form 8-K BurgerFi International, For: May 15
-
Form 8-K Guerrilla RF, Inc. For: May 15
-
Form 13F-HR Arias Resource Capital For: Mar 31
-
Form 6-K Ayr Wellness Inc. For: May 15
-
Form 8-K Acurx Pharmaceuticals, For: May 15
-
Form 8-K Zapata Computing Holding For: May 15
-
Form 10-Q Volato Group, Inc. For: Mar 31
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Barnes Alane P
-
Form 8-K Edible Garden AG Inc For: May 15
-
Form 8-K BIO-PATH HOLDINGS, INC. For: May 15
-
Form 13F-NT Bank of Singapore Ltd For: Mar 31
-
Form 20-F Xinyuan Real Estate Co., For: Dec 31
-
Form 13F-HR ABG Innovation Capital For: Mar 31
-
Form 8-K Volato Group, Inc. For: May 15
-
Form 13F-HR Fullerton Fund Managemen For: Mar 31
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Stonehouse Jon P
-
Form 10-Q Katapult Holdings, Inc. For: Mar 31
-
Form 6-K ONCOLYTICS BIOTECH INC For: May 15
-
Form 8-K Olema Pharmaceuticals, For: May 15
-
Form 8-K TREVENA INC For: May 15
-
Form 8-K Venus Concept Inc. For: May 15
-
Form 6-K RADCOM LTD For: May 15
-
Form 8-K Cabaletta Bio, Inc. For: May 15
-
Form 4 BIOCRYST PHARMACEUTICALS For: May 13 Filed by: Gayer Charles K
-
Form 13F-HR MUFG Securities EMEA For: Mar 31
-
Form 6-K Flex LNG Ltd. For: May 15
-
Form 6-K COMPUGEN LTD For: May 15
-
Form 8-K Perspective Therapeutics For: May 15
-
Form 10-K Prestige Consumer Health For: Mar 31
-
Form 13F-HR Fundsmith LLP For: Mar 31
-
Form 10-Q PSQ Holdings, Inc. For: Mar 31
-
Form 8-K Predictive Oncology Inc. For: May 15
-
Form 8-K Katapult Holdings, Inc. For: May 15
-
Form 8-K DecisionPoint Systems, For: May 15
-
Form 13F-NT Quilter Cheviot Internat For: Mar 31